[Congressional Record Volume 166, Number 119 (Monday, June 29, 2020)]
[Senate]
[Page S3718]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 2273. Mr. PETERS submitted an amendment intended to be proposed by 
him to the bill S. 4049, to authorize appropriations for fiscal year 
2021 for military activities of the Department of Defense, for military 
construction, and for defense activities of the Department of Energy, 
to prescribe military personnel strengths for such fiscal year, and for 
other purposes; which was ordered to lie on the table; as follows:

       At the end of section 806, add the following:
       (d) Medical Supply Chain Preparedness Measures.--
       (1) In general.--Not later than 18 months after the date of 
     the enactment of this Act, the Director of the Defense 
     Logistics Agency shall submit to the Committees on Armed 
     Services of the Senate and the House of Representatives--
       (A) the results of a study on contracts entered into by the 
     Director relating to health readiness of the Armed Forces to 
     assess--
       (i) the reliance by the Department of Defense on foreign 
     sources of active pharmaceutical ingredients, drugs, and 
     medical devices; and
       (ii) the redundancy planning of the Department to mitigate 
     shortages of drugs and medical devices; and
       (B) a list of critical drugs for the Department of Defense 
     compiled by the Director of the Defense Logistics Agency, in 
     coordination with the Director of the Defense Health Agency.
       (2) Definitions.--In this subsection:
       (A) Drug.--The term ``drug'' has the meaning given that 
     term in section 201 of the Federal Food, Drug, and Cosmetic 
     Act (21 U.S.C. 321).
       (B) Medical device.--The term ``medical device'' has the 
     meaning given the term ``device'' in such section 201.
                                 ______